Photo from Yakup Ergün/X
May 21, 2024, 15:41
Yakup Ergün: A valuable retrospective study on PD-L1 alteration after NAC in TNBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:
“A valuable retrospective study on PD-L1 alteration after NAC in TNBC.
- 22% of patients with residual tumors showed alteration in PD-L1.
- Almost all of these alterations were negative to positive changes.
- Platinum use associated with increased PD-L1.
- PD-L1 positivity after NAC associated with better RFS.”
Proceed to the article.
Source: Yakup Ergün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59
Nov 13, 2024, 10:54
Nov 13, 2024, 10:45